Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Inventory: 2014-2024

Historic Inventory for Ocular Therapeutix (OCUL) over the last 11 years, with Dec 2024 value amounting to $3.0 million.

  • Ocular Therapeutix's Inventory rose 45.03% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 45.03%. This contributed to the annual value of $3.0 million for FY2024, which is 31.89% up from last year.
  • As of FY2024, Ocular Therapeutix's Inventory stood at $3.0 million, which was up 31.89% from $2.3 million recorded in FY2023.
  • Ocular Therapeutix's Inventory's 5-year high stood at $3.0 million during FY2024, with a 5-year trough of $1.2 million in FY2020.
  • Over the past 3 years, Ocular Therapeutix's median Inventory value was $2.3 million (recorded in 2023), while the average stood at $2.4 million.
  • Data for Ocular Therapeutix's Inventory shows a peak YoY soared of 57.92% (in 2022) over the last 5 years.
  • Over the past 5 years, Ocular Therapeutix's Inventory (Yearly) stood at $1.2 million in 2020, then climbed by 4.08% to $1.2 million in 2021, then surged by 57.92% to $2.0 million in 2022, then increased by 16.77% to $2.3 million in 2023, then skyrocketed by 31.89% to $3.0 million in 2024.